ADIB DEYAA (Chief Medical Officer) purchased 36.9% of their position (22.12K shares) of KYNTRA BIO, INC. on the open market
Open‑market purchase worth $25.9K — a major conviction buy. The strongest form of insider conviction signal.
P · 1 purchase
Filed: 6/13/2024ACC: 0001415889-24-016677
Officer· Chief Medical Officer
Since Apr 2024
+22.12K
Net shares
Net buyer
$25.9K
Total acquired
1
Open market trades
1B · 0S
1
Total transactions
22.12K acquired
Non-Derivative Transactions1
Common Stock
Direct
Shares
+22.12K
Price / share
$1.17
Trade value
$25.88K
% of position
36.9%
6/12/2024
60K→82.12K
Total
Net shares
+22.12K
Net value
$25.88K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 6/12/2024 | P · Purchase | +22.12K | $1.17 | $25.88K | 36.9% | 60K | 82.12K |
| Total | +22.12K | $25.88K | ||||||
Derivative Transactions0
No derivative transactions reported